Examen Ltd

Back to portfolio

In vitro diagnostics company specialising in male infertility and miscarriage testing.

Examen is a diagnostics company. Our mission is to transform the diagnosis and treatment of male reproductive problems. 

Examen was set up in response to public demand for our market–leading sperm DNA fragmentation test, the SpermComet®. SpermComet® was developed following more than twenty years of research into better tests for male infertility and treatment. Now we can provide accurate information for male fertility diagnosis and better prediction of fertility treatment success. The founder of Examen is internationally acclaimed academic in male fertility; Professor Sheena Lewis FRSB.

Key Facts

  • We provide a unique, accurate molecular test that checks out the quality of sperm DNA.
  • High sperm DNA damage causes male infertility
  • High sperm DNA damage leads to poor fertility treatment success
  • High sperm DNA damage causes miscarriage
  • Having the test gives couples new options and saves them time, money and heartbreak
    Visit website
    • Life Science

      VascVersa Ltd

      We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.

      Read more
    • Engineering, Scientific

      Sengenia Ltd

      Sengenia was founded over a decade ago and is solely focused on bringing innovative sensing solutions to a wide range of sectors.

      Read more
    • Life Science

      Biocolor Ltd

      Biocolor designs, manufactures and distributes research tools for use by cell biology and bioengineering communities.

      Read more
    • Digital, Life Science

      Sonrai Analytics

      Sonrai Analytics focuses on providing a cloud–enabled bespoke knowledge platform to conduct modern–day analytics for ‘big data’

      Read more